CapitaLand Integrated Commercial Trust
SGX:C38U
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CapitaLand Integrated Commercial Trust
SGX:C38U
|
SG |
|
Genpact Ltd
NYSE:G
|
BM |
|
EPR Properties
NYSE:EPR
|
US |
|
Ajanta Soya Ltd
BSE:519216
|
IN |
|
M&G PLC
LSE:MNG
|
UK |
|
S
|
Sentral REIT
KLSE:SENTRAL
|
MY |
|
I
|
Insulet Corp
XBER:GOV
|
US |
|
N
|
Nano Nuclear Energy Inc
NASDAQ:NNE
|
US |
|
USANA Health Sciences Inc
NYSE:USNA
|
US |
|
S
|
Sun International Ltd
XBER:RY1B
|
ZA |
|
Marathon Oil Corp
NYSE:MRO
|
US |
Wall St Price Targets
C38U Price Targets Summary
CapitaLand Integrated Commercial Trust
According to Wall Street analysts, the average 1-year price target for C38U is 2.75 with a low forecast of 2.42 and a high forecast of 3.1 .
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C38U's stock price target?
Price Target
2.75
According to Wall Street analysts, the average 1-year price target for C38U is 2.75 with a low forecast of 2.42 and a high forecast of 3.1 .
What is the Revenue forecast for CapitaLand Integrated Commercial Trust?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 6%.
What is the Operating Income forecast for CapitaLand Integrated Commercial Trust?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 5 years is 7%.
What is the Net Income forecast for CapitaLand Integrated Commercial Trust?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 5 years is 4%.
